Material Agreements

Datavault AI Inc. entered into Placement Agency Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC valued at cash fee of $4.2 million (effective 2026-05-03).

“In connection with the Offering, the Company entered into a Placement Agency Agreement, dated as of May 3, 2026, with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “Placement Agent”), pursuant to which the Placement Agent agreed to serve as the sole placement agent for the issuance and sale of securities of the Company pursuant to the Purchase Agreement.”

Datavault AI Inc. entered into Securities Purchase Agreement with certain institutional investors valued at approximately $60.0 million (effective 2026-05-03).

“On May 3, 2026, Datavault AI Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”) an aggregate of 109,090,910 shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”).”

Reborn Coffee, Inc. entered into Securities Purchase Agreement with the purchasers named therein (the "Investors") valued at $21 million (effective 2026-04-29).

“On April 29, 2026, Reborn Coffee, Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Agreement”) with the purchasers named therein (the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement, shares of its common stock (the “Shares”) in two closings for aggregate gross proceeds of $21 million”

Inmune Bio, Inc. entered into Amended and Restated Material Transfer and License Agreement with Anthony Nolan valued at an annual cap of £5,000,000 (effective 2026-04-29).

“On April 29, 2026, INmune Bio Inc. (the “Company”) entered into an amended and restated Material Transfer and License Agreement (the “ Amended and Restated Agreement ”) with INmune Bio International (“ IMB ”), a company incorporated in England and the Company’s wholly-owned subsidiary, and Anthony Nolan (“ AN ”), a company limited by guarantee incorporated in England, which amended and restated the original agreement signed by IMB and AN on November 29, 2017, as amended and restated on March 21, 2023 (the “ Original Agreement ”).”

BrightView Holdings, Inc. amended Amendment No. 10 to the Credit Agreement with JPMorgan Chase Bank, N.A. valued at Extended maturity date to April 22, 2031; reduced interest rates on Revolving Credit Loans (effective 2026-05-04).

“BrightView Holdings, Inc. (the “Company”), its wholly-owned subsidiary, BrightView Landscapes, LLC (the “Credit Agreement Borrower”), the other credit parties party thereto, the lenders or other financial institutions or entities party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent (the “Agent”), entered into Amendment No. 10 to the Credit Agreement dated as of May 4, 2026 (the “Credit Agreement Amendment”), which amends the Credit Agreement, dated as of December 18, 2013, by and among the Company, the Credit Agreement Borrower and the lenders or other financial institutions or entities from time to time party thereto and the Agent (as previously amended, the “Existing Credit Agreement”) to, among other things, extend the maturity date of loans under the revolving credit facility (“Revolving Credit Loans”) and reduce the interest rate applicable to Revolving Credit Loans, as described further below.”

Vireo Growth Inc. entered into Arrangement Agreement with FLUENT Corp. (effective 2026-04-29).

“Vireo Growth Inc. (“Vireo” or the “Company”) entered into an arrangement agreement (the “Arrangement Agreement”) with FLUENT Corp. (“FLUENT”), pursuant to which Vireo agreed to acquire all of the issued and outstanding shares of FLUENT by way of a court-approved plan of arrangement under Section 182 of the Business Corporations Act (Ontario)”

Scilex Holding Co entered into ACEA-PHOE SAA with Phoenix Asia Holdings Limited valued at $1,000,000,000.00 (effective 2026-05-04).

“On May 4, 2026, ACEA Therapeutics, Inc. (“ACEA Thera”), an indirect minority owned subsidiary of Scilex Holding Company (the “Company”), entered into a Stock Acquisition Agreement (the “ACEA-PHOE SAA”) with Phoenix Asia Holdings Limited, a company organized under the laws of the Cayman Islands (“Phoenix Asia”), and ACEA Pharma, Inc., a wholly owned subsidiary of ACEA Thera and an exempted company incorporated with limited liability in the Cayman Islands (“ACEA Pharma”), pursuant to which ACEA Thera agreed to transfer and sell, and Phoenix Asia agreed to purchase, 100% of the issued and outstanding shares of common stock of ACEA Pharma in exchange for the delivery to ACEA Thera of 100,000,000 newly-issued ordinary shares at $10.00 per share, par value $0.00001 per share, of Phoenix Asia (the “Stock Acquisition”), the value of which was as agreed by the parties to be $1,000,000,000.00.”

Exodus Movement, Inc. terminated 2025 Stock Purchase Agreement.

“the parties agreed that effective automatically upon the Delivery Date, (a) the 2025 Stock Purchase Agreement will be terminated”

Exodus Movement, Inc. entered into Stock and Asset Purchase Agreement with Baanx US Corp., W3C Corp., and Garth Howat valued at $30.0 million (effective 2026-05-01).

“On May 1, 2026, the Company entered into a Stock and Asset Purchase Agreement (the "Purchase Agreement") with Baanx US Corp. (the "Baanx US"), W3C and Howat, pursuant to which the Company acquired all of the issued and outstanding shares of capital stock of Baanx US and agreed to acquire certain other assets from Howat (the "Transaction").”

Clene Inc. entered into Underwriting Agreement with Canaccord Genuity LLC valued at 1,000,000 shares of common stock at $7.00 per share for estimated net proceeds of $6.4 million (effective 2026-05-05).

“On May 5, 2026, Clene Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Canaccord Genuity LLC as underwriter, pursuant to which the Company agreed to issue and sell an aggregate of 1,000,000 shares of the Company’s common stock, par value $0.0001 per share (“common stock”), at an offering price of $7.00 per share.”

Finance of America Companies Inc. amended the Amendment with Onity Mortgage Corporation valued at unpaid principal balance of $5.1 billion (effective 2026-04-30).

“On April 30, 2026, Finance of America Reverse LLC (“FAR”), an indirect subsidiary of Finance of America Companies Inc., and Onity Mortgage Corporation (formerly known as PHH Mortgage Corporation) (“OMC”) entered into an amendment (the “Amendment”) to the parties’ agreements for the sale of OMC’s reverse mortgage servicing portfolio and certain reverse originations assets.”

International Media Acquisition Corp. amended Amended and Restated Merger Agreement with VCI Holdings Limited, Vietnam Biofuels Development Joint Stock Company, Ethanol Quang Nam Production Company Limited, Valix Limited, Newbio Merger Limited valued at Issuance of up to 98,000,000 Purchaser Class A Ordinary Shares and 2,000,000 Purchaser Class B Ordin (effective 2026-04-30).

“On April 30, 2026, IMAQ entered into an amended and restated merger agreement (as amended from time to time, the “ Merger Agreement ”) by and among (i) IMAQ, (ii) VCI, (iii) Ethanol Quang Nam Production Company Limited (“ EQN ”, together with VCI and their respective subsidiaries, the “ Company Group ”), (iv) VNB, (v) Valix Limited, a British Virgin Islands business company (the “ Purchaser ”), and (vi) Newbio Merger Limited, a British Virgin Islands business company (“ Merger Sub ”), to amend and restate the Original Merger Agreement.”

Roadzen Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at 6.0% cash fee of aggregate gross proceeds and $30,000 expense reimbursement (effective 2026-05-04).

“On May 4, 2026, Roadzen Inc. (the "Company") entered into a placement agency agreement (the "Agency Agreement") with Maxim Group LLC (the "Placement Agent") and a securities purchase agreement (the "Purchase Agreement") with purchasers for the purchase and sale, in a best efforts offering (the "Offering"), of 4,705,870 of the Company’s ordinary shares, par value $0.0001 per share ("Ordinary Shares"), at an offering price of $1.70 per Share.”

Roadzen Inc. entered into Securities Purchase Agreement with purchasers valued at 4,705,870 ordinary shares at $1.70 per share; gross proceeds of $7,999,979 (effective 2026-05-04).

“On May 4, 2026, Roadzen Inc. (the "Company") entered into a placement agency agreement (the "Agency Agreement") with Maxim Group LLC (the "Placement Agent") and a securities purchase agreement (the "Purchase Agreement") with purchasers for the purchase and sale, in a best efforts offering (the "Offering"), of 4,705,870 of the Company’s ordinary shares, par value $0.0001 per share ("Ordinary Shares"), at an offering price of $1.70 per Share.”

C2 Blockchain, Inc. entered into Note with Labrys Fund II, L.P. valued at $120,000 (effective 2026-04-23).

“On April 23, 2026, C2 Blockchain, Inc. (the “Company”) issued a convertible promissory note (the “Note”) to Labrys Fund II, L.P. (the “Holder”) in the principal amount of $120,000, reflecting a purchase price of $100,000 and an original issue discount of $20,000.”

ConnectM Technology Solutions, Inc. entered into Blue Cloud Agreement with Blue Cloud Softech Solutions Limited valued at 170 million equity shares of Blue Cloud (effective 2026-04-06).

“On April 6, 2026, ConnectM Technology Solutions, Inc. (the “Company”) entered into a Share Swap Agreement (the “Blue Cloud Agreement”) by and among the Company, AstraBridge Inc., an unaffiliated third party (“AstraBridge”), and Blue Cloud Softech Solutions Limited (“Blue Cloud”).”

First Seacoast Bancorp, Inc. entered into Agreement and Plan of Merger with Cambridge Financial Group, Inc. (effective 2026-05-04).

“On May 4, 2026, First Seacoast Bancorp, Inc. (the “Company”), the holding company of First Seacoast Bank, and Cambridge Financial Group, Inc. (“Cambridge Financial”), the mutual holding company of Cambridge Savings Bank, entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which the Company will merge with Cambridge Financial, with Cambridge Financial as the surviving corporation (the “Merger”).”

RenX Enterprises Corp. entered into Purchase Agreement with certain institutional investors valued at up to $87,000,000 (effective 2026-04-30).

“On April 30, 2026, RenX Enterprises Corp. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (the “Purchasers”) related to a tranched private placement transaction (the “Private Placement”) of Senior Convertible Notes (“Notes”) and warrants (“Warrants”) to purchase shares of the Company’s common stock, par value $0.001 per share (“Common Stock”) as more particularly set forth below. Pursuant to the Purchase Agreement, the Company (i) issued and sold to the Purchasers, at the initial closing on May 4, 2026 (the “Initial Closing”), Notes in the aggregate principal amount of $6,300,000 (the “Initial Notes”) and warrants (the “Initial Warrants”) to purchase an aggregate of 3,917,099 shares of Common Stock (which is equal to 180% of the face value of the Initial Notes divided by $2.895 (the “Initial Conversion Price”)), (ii) agreed to issue and sell to the Purchasers, at a second closing (the “Second Closing”), Notes”

Bowhead Specialty Holdings Inc. amended Amended and Restated Insurance Trust Agreement with American Family Mutual Insurance Company, S.I.; U.S. Bank National Association valued at Trust Amendment amends collateralization requirements to reflect increased collateralization require (effective 2026-05-04).

“On May 4, 2026, BICI, AFMIC and US Bank National Association entered into Amendment No. 1 (the “Trust Amendment”) to the Amended and Restated Insurance Trust Agreement, dated as of May 23, 2024, among BICI, AFMIC and U.S. Bank National Association, as trustee (the “Amended and Restated Trust Agreement”).”

Bowhead Specialty Holdings Inc. amended Amended and Restated Quota Share Reinsurance Agreement with American Family Mutual Insurance Company, S.I. valued at Amendment modifies termination threshold, notice period, ceding commission, and collateralization re (effective 2026-05-04).

“On May 4, 2026, Bowhead Insurance Company, Inc. (“BICI”), a wholly-owned subsidiary of Bowhead Specialty Holdings Inc., (the “Company”), entered into Amendment No. 1 (the “Amendment”) to the Amended and Restated Quota Share Reinsurance Agreement, dated as of May 23, 2024, between American Family Mutual Insurance Company, S.I. (“AFMIC”), and the Company (the “Amended and Restated Quota Share Agreement”).”

Drugs Made In America Acquisition Corp. amended Amendment No. 2 to the Merger Agreement with Power Analytics Global Corp valued at completed notice address provisions including street addresses and email addresses (effective 2026-04-30).

“Also on April 30, 2026, DMAA and PAGC entered into Amendment No. 2 to the Merger Agreement (“Amendment No. 2,” and together with Amendment No. 1, the “Amendments”) for the purpose of completing the notice address provisions set forth in Section 11.1, including the parties’ respective street addresses and email addresses.”

Drugs Made In America Acquisition Corp. amended Amendment No. 1 to the Merger Agreement with Power Analytics Global Corp valued at revised governing law and jurisdiction provisions, clarified termination provisions, revised notice (effective 2026-04-30).

“On April 30, 2026, DMAA and PAGC entered into Amendment No. 1 to the Merger Agreement (“Amendment No. 1”) for the purpose of correcting certain inconsistencies and incomplete items in the Merger Agreement prior to public disclosure.”

Drugs Made In America Acquisition Corp. entered into Definitive Merger Agreement with Power Analytics Global Corp valued at target enterprise valuation of $1.0 billion, Floor Valuation of $300 million, post-closing ownership (effective 2026-04-29).

“On April 29, 2026, Drugs Made In America Acquisition Corp., a Cayman Islands exempted company (the “Company” or “DMAA”), entered into a Definitive Merger Agreement (the “Merger Agreement”) with Power Analytics Global Corp, a Delaware corporation engaged in the business of artificial intelligence, advanced analytics and quantum-resistant security solutions (“PAGC”).”

Picard Medical, Inc. entered into Warrant Issuance and Exchange Agreement with holder (the “Holder”) (effective 2026-05-05).

“On May 5, 2026, Picard Medical, Inc. (the “Company”) entered into a Warrant Issuance and Exchange Agreement (the “Exchange Agreement”) with the holder (the “Holder”) of certain of the Company’s outstanding warrants to purchase shares of the Company’s common stock”

CH4 Natural Solutions Corp entered into Registration Rights Agreement with CH4 Natural Solutions Acquisition Sponsor LLC, CH4 Natural Solutions Acquisition Security Holdings, LLC (effective 2026-04-30).

“• A Registration Rights Agreement, dated April 30, 2026, among the Company, the Sponsor and the Unit Holdings Sponsor. • An Administrative Support Agreement, dated April 30, 2026, between the Company and an affiliate of the Sponsor.”

CH4 Natural Solutions Corp entered into Private Placement Units Purchase Agreement with CH4 Natural Solutions Acquisition Security Holdings, LLC (effective 2026-04-30).

“• A Private Placement Units Purchase Agreement (the “ Purchase Agreement ”), dated April 30, 2026, among the Company and the Unit Holdings Sponsor.”

CH4 Natural Solutions Corp entered into Public Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-04-30).

“• A Public Warrant Agreement, dated April 30, 2026, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.”

CH4 Natural Solutions Corp entered into Private Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-04-30).

“• A Private Warrant Agreement, dated April 30, 2026, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.”

CH4 Natural Solutions Corp entered into Underwriting Agreement with Santander US Capital Markets LLC (effective 2026-04-30).

“The Units were issued pursuant to an underwriting agreement, dated April 30, 2026, between the Company and Santander US Capital Markets LLC (“ Santander ”).”

Stonepeak-Plus Infrastructure Fund LP amended Amended Investment Advisory Agreement with Stonepeak-Plus Infrastructure Fund Advisors LLC (effective 2026-05-04).

“On May 4, 2026, Stonepeak-Plus Infrastructure Fund LP (the “Fund”) entered into the Second Amended and Restated Investment Advisory Agreement (the “Amended Investment Advisory Agreement”) with Stonepeak-Plus Infrastructure Fund Advisors LLC (the “Investment Advisor”), which amended and restated the Amended and Restated Investment Advisory Agreement dated March 30, 2026.”

ARC Group Acquisition I Corp. entered into Private Units Purchase Agreement with MFH 2, LLC (the "Sponsor") (effective 2026-04-29).

“● Private Units Purchase Agreement, dated April 29, 2026, by and among the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and is incorporated”

ARC Group Acquisition I Corp. entered into Underwriting Agreement with ARC Group Securities LLC (effective 2026-04-29).

“Underwriting Agreement, dated April 29, 2026, by and between the Company and ARC Group Securities LLC, as representatives of the underwriters”

Mountain Crest Acquisition 6 Corp. entered into Private Placement Unit Purchase Agreement with Mountain Crest Holdings 6 LLC, D. Boral Capital LLC (effective 2026-04-29).

“Private Placement Unit Purchase Agreement, dated April 29, 2026, by and between the Company, Mountain Crest Holdings 6 LLC and D. Boral Capital LLC”

Mountain Crest Acquisition 6 Corp. entered into Registration Rights Agreement with certain securityholders of the Company (effective 2026-04-29).

“Registration Rights Agreement, dated April 29, 2026, by and among the Company and certain securityholders of the Company”

Mountain Crest Acquisition 6 Corp. entered into Underwriting Agreement with D. Boral Capital LLC (effective 2026-04-29).

“In connection therewith, the Company entered into the following agreements previously filed as exhibits to the Registration Statement: ● Underwriting Agreement, dated April 29, 2026, by and between the Company and D. Boral Capital LLC; ● Rights Agreement, dated April 29, 2026, by and between the Company and Continental Stock Transfer & Trust Company; ● Letter Agreement, dated April 29, 2026, by and between the Company’s officers, directors, D.”

FARMER BROTHERS CO terminated Credit Agreement with Wells Fargo Bank, National Association.

“on the Closing Date, the Company terminated the Credit Agreement (the “Credit Agreement”), dated as of April 26, 2021, by and among the Company and certain subsidiaries of the Company named therein, as borrowers, the lenders party thereto from time to time and Wells Fargo Bank, National Association, as administrative agent and lender.”

MSA Safety Inc entered into Sale and Purchase Agreement with Autronica Finco Lux S.À.R.L. and Spectrum Safety Solutions Purchaser, LLC valued at approximately $555 million (effective 2026-05-05).

“On May 5, 2026, MSA Safety Incorporated (“ MSA ”) and Aegir Safety Holdings AS (“ Safety Holdings ”), an indirect wholly owned subsidiary of MSA, entered into an agreement to acquire Autronica Buyer Norway AS and its affiliated companies (referred to herein collectively as “ Autronica ”). Pursuant to a Sale and Purchase Agreement (the “ SPA ”), by and among MSA, Safety Holdings, Autronica Finco Lux S.À.R.L. (“ Seller ”) and Spectrum Safety Solutions Purchaser, LLC (“ Seller Parent ”), Safety Holdings will acquire the entire issued share capital of Autronica (the “ Transaction ”).”

MODINE MANUFACTURING CO amended Amendment No. 2 with lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (effective 2026-04-30).

“On April 30, 2026, Modine Manufacturing Company (the “Company”) and Airedale International Air Conditioning Limited, as borrowers (collectively, the “Borrowers”), entered into Amendment No. 2 (the “Amendment”) to the Sixth Amended and Restated Credit Agreement, dated as of July 10, 2025 (as previously amended, the “Credit Agreement”), by and among the Borrowers, the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent.”

AVIS BUDGET GROUP, INC. amended Fourth Amendment to Fourth Amended and Restated Series 2015-3 Supplement valued at increased from approximately $109 million to $132 million (effective 2026-04-30).

“hich is attached hereto as Exhibit 10.1, and the Fourth Amendment to Fourth Amended and Restated Series 2015-3 Supplement, a copy of”

AVIS BUDGET GROUP, INC. amended Fourth Amendment to Sixth Amended and Restated Series 2010-6 Supplement valued at increased from approximately $2.227 billion to $2.628 billion (effective 2026-04-30).

“On April 30, 2026 (the “Closing Date”), Avis Budget Group, Inc.’s (the “Company”, “we” or “our”) Avis Budget Rental Car Funding (AESOP) LLC subsidiary (“ABRCF”) completed an amendment and extension of its asset-backed variable-funding financing facilities”

Viskase Holdings, Inc. entered into Section 382 Rights Agreement with Continental Stock Transfer & Trust Company (effective 2026-05-05).

“On April 30, 2026 (the “Rights Dividend Declaration Date”), the Board of Directors (the “Board”) of Viskase Holdings, Inc. (formerly known as Enzon Pharmaceuticals, Inc.) (the “Company”) adopted a Section 382 Rights Agreement (the “Section 382 Rights Agreement”)”

UNITIL CORP entered into Note Purchase Agreement with State Farm Life Insurance Company, State Farm Life and Accident Assurance Company and CoBank, ACB valued at $23,000,000 and $17,000,000 (effective 2026-04-30).

“On April 30, 2026, Fitchburg Gas and Electric Light Company (“Fitchburg”), an electric and natural gas distribution utility subsidiary of Unitil Corporation (the “Company” or the “Registrant”), entered into a Note Purchase Agreement with State Farm Life Insurance Company, State Farm Life and Accident Assurance Company and CoBank, ACB (the “Note Purchase Agreement”) pursuant to which it issued and sold (i) $23,000,000 of 5.62% Senior Unsecured Notes, Series 2026A, due April 30, 2036 and (ii) $17,000,000 of 5.87% Senior Unsecured Notes, Series 2026B, due April 30, 2041 (collectively, the “Notes”).”

ONITY GROUP INC. amended the Amendment with Finance of America Reverse LLC valued at approximately $105-115 million (effective 2026-04-30).

“On April 30, 2026, Onity Group Inc. (“Onity” or the “Company”), through its wholly-owned subsidiary Onity Mortgage Corporation (“OMC”), and Finance of America Reverse LLC (“FAR”) entered into an amendment (the “Amendment”) to the parties’ agreements for the sale of Onity’s reverse mortgage servicing portfolio and certain reverse originations assets.”

Oncotelic Therapeutics, Inc. entered into Asset Transfer Agreement with Autotelic Inc. (effective 2026-04-30).

“On April 30, 2026, the Company and Autotelic Inc. (“Autotelic”) entered into an asset transfer agreement (the “Asset Transfer Agreement”)”

GREENBRIER COMPANIES INC amended Third Amendment to Amended and Restated Credit Agreement with Bank of America, N.A., as Administrative Agent valued at $300 million (effective 2026-05-05).

“Greenbrier Leasing Company LLC (“GLC”), a wholly-owned subsidiary of Greenbrier, entered into a Third Amendment to Amended and Restated Credit Agreement (the “Third Amendment”), with BofA, as Administrative Agent”

GREENBRIER COMPANIES INC amended Sixth Amendment to Fourth Amended and Restated Credit Agreement with Bank of America, N.A., as Administrative Agent (effective 2026-05-05).

“On May 5, 2026 (the “Effective Date”), The Greenbrier Companies, Inc. (“Greenbrier”) entered into a Sixth Amendment to Fourth Amended and Restated Credit Agreement (the “Sixth Amendment”), with Bank of America, N.A. (“BofA”), as Administrative Agent”

Track Group, Inc. entered into Purchase Agreement with certain accredited investors valued at approximately $10,315,000 (effective 2026-04-30).

“On April 30, 2026, Track Group, Inc., a Delaware corporation (the “ Company ”), entered into Securities Purchase Agreements (the “ Purchase Agreement ”) with certain accredited investors (the “ Investors ”), for the private placement (the “ Private Placement ”) of (i) 29,471,429 shares of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”) (the “ PIPE Shares ”) at a price per PIPE Share of $0.35, and (ii) 750,000 warrants to purchase shares of Common Stock (the “ PIPE Warrants ”). for aggregate gross proceeds of approximately $10,315,000.”

MACROGENICS INC amended First Amendment to the Purchase and Sale Agreement with Sagard Healthcare Partners valued at $60.0 million additional cash payment, aggregate purchase price $130.0 million (effective 2026-05-01).

“On May 1, 2026, MacroGenics, Inc. (the “Company”) and an entity affiliated with Sagard Healthcare Partners (“Sagard”) entered into a First Amendment (the “First Amendment”) to the Purchase and Sale Agreement, dated as of June 9, 2025 (the “Royalty Purchase Agreement”), pursuant to which the Company previously sold to Sagard its right to receive royalties on global net sales of ZYNYZ (retifanlimab-dlwr) under the Company’s Global Collaboration and License Agreement dated as of October 24, 2017, as amended (the “License Agreement”), with Incyte Corporation.”

CBRE GROUP, INC. entered into underwriting agreement with Wells Fargo Securities, LLC, BofA Securities, Inc., Citigroup Global Markets Inc. and Scotia Capital (USA) Inc. on behalf of the several underwriters (effective 2026-04-27).

“The Notes were sold pursuant to an underwriting agreement, dated as of April 27, 2026, among Services, the Company and Wells Fargo Securities, LLC, BofA Securities, Inc., Citigroup Global Markets Inc. and Scotia Capital (USA) Inc. on behalf of the several underwriters listed in Schedule A thereto.”

CBRE GROUP, INC. entered into Thirteenth Supplemental Indenture with Computershare Trust Company, National Association, as trustee (effective 2026-05-04).

“the Thirteenth Supplemental Indenture entered into among Services, the Company and the Trustee on May 4, 2026 (the “Thirteenth Supplemental Indenture” and, together with the Base Indenture, the “Indenture”).”